Purpose: To determine the degree and variability of radiation exposure to t
he general public from patients after I-125 or Pd-103 prostate brachytherap
y,
Methods and Materials: Radiation exposure measurements were made from 38 co
nsecutive, unselected patients with stage T1 or T2 prostatic carcinoma who
had transperineal I-125 or Pd-103 implants at the University of Washington
in 1998,
Results: The exposure rate at the anterior skin surface following a I-125 i
mplant ranged from 2.2 to 8.9 mrem/hour (average: 5.0), The exposure rate a
t the anterior skin surface from a Pd-103 implant ranged from 0.5 to 4.9 mr
em/hour (average: 1.7). Based on the current Nuclear Regulatory Commission
(NRC) regulations the time required to reach the annual limit at the anteri
or skin surface would be 20 hours for I-125 and 59 hours for Pd-103, For ex
posure at the lateral skin surface, the times would exceed 500 hours for ei
ther isotope.
Conclusions: This data suggest that patients need not be concerned about be
ing a radiation risk to the general public following their procedure. (C) 1
999 Elsevier Science Inc.